¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"working relationship"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • symbiotic relationship
    °ø»ý°ü°è
  • time dose relationship
    ½Ã°£¿ë·®°ü°è
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • structure activity relationship
    (È­ÇÐ)±¸Á¶ Ȱ¼º »ó°ü°ü°è
  • therapeutic relationship
    Ä¡·áÀû °ü°è(~μÌõ).
  • time dose relationship
    ½Ã°£¿ë·®°ü°è.
  • working
    °¡°ø(Ê¥Íï).
  • working bite
    ÀÛ¾÷Ãø±³ÇÕ(íÂåöö°Îáùê).
  • working distance
    ÀÛµ¿°Å¸®(íÂÔÑËåìÆ), ÀÛ¾÷°Å¸®(íÂåöËåìÆ).
  • working distance
    ÀÛ¾÷°Å¸®
  • working distance
    ÀÛµ¿°Å¸®(ËöËÄ˧Ëö), ÀÛ¾÷°Å¸®(ËöËâ˧Ëö).
  • working environment
    ±Ù¹«È¯°æ(Ë»ËÎÌ·Ë­).
  • working model
    ÀÛ¾÷¸ðÇü(ËöËâËÎÌ´).
  • working model for bridgework
    ±³ÀÇÄ¡¿ë ÀÛ¾÷¸ðÇü(ÎéëùöÍéÄíÂåöÙ¼úþ).
  • working point
    ÀÛ¿ëÁ¡(íÂéÄïÇ).
  • working power
    ³ë·Â·Â(ËÈËçËç).
  • working side
    ÀÛ¾÷Ãø(íÂåöö°).
  • working stress
    »ç¿ëÀÀ·Â(ÞÅéÄëëæ³).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
WP weakly positive; wedge pressure; wet pack; wettable powder; whirlpool; white pulp; word processor; w...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
DPFR diastolic pressure-flow relationship
ESFL end-systolic force-length relationship
ESPVR end-systolic pressure-volume relationship
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CCRT Core Conflictual Relationship Theme
ESPVR End-systolic pressure-volume relationship
LSER Linear Solvation Energy Relationship
LFER linear free energy relationship
QSAR Quantitative Structure Activity Relationship
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • specific dentist-patient relationship
    µ¶Æ¯ÇÑ Ä¡°ú ÀÇ»ç-ȯÀÚ °ü°è
  • symbiotic relationship
    °ø»ý °ü°è
  • temporal relationship
    ½Ã°£Àû °ü·Ã¼º
  • hot working
    °í¿Â °¡°ø, ¿­°£ °¡°ø
    Àç°áÁ¤ ¿Âµµ À̻󿡼­ÀÇ °¡°ø.
  • non-working
    ºñÀÛ¾÷
  • non-working occlusal contact
    ºñÀÛ¾÷Ãø ±³ÇÕ Á¢ÃË
  • non-working side
    ºñÀÛ¾÷Ãø
    ÀÇÄ¡ ¶Ç´Â ÀÚ¿¬ Ä¡¿­¿¡ À־ ÇϾÇÀÌ ÀúÀÛ ¿îµ¿À» ÇÏ´Â ¹Ý´ëÂÊ, Áï ºñÀúÀÛÃøÀ» ÀǹÌÇÑ´Ù.
  • working
    °¡°ø
    Ä¡°ú ¿µ¿ª¿¡¼­ Àç·á¸¦ ¸ñÀûÇÏ´Â ÇüÅ·Π¼ºÇüÇÏ´Â °úÁ¤À¸·Î È¥ÇÕ, ¸ðÇü Á¦ÀÛ, Á¶°¢, ¸Å¸ô, ¿ëÀ¶, ÁÖÁ¶, ¿¬¸¶, ¿Ï¼º, ¿­ ó¸®, Ã༺ µî ¸ðµç Á¶ÀÛÀ» ÇÏ´Â ÇàÀ§¸¦ ¶æÇÑ´Ù.
  • working bite
    ÀÛ¾÷Ãø ¹°¸², ÀÛ¾÷Ãø ±³ÇÕ
    ÇϾÇÀÌ ³»ÃøÀ¸·Î À̵¿µÇ´Â ÂÊ¿¡¼­ »óÇÏ¾Ç Ä¡¾Æ°£¿¡ ¿À´Â ±³ÇÕ¸é Á¢ÃËÀ¸·Î, Àü¹æÀ̳ª ÈĹ濡¼­ °üÂûÇÏ¸é »óÇÏ¾Ç Ä¡¾Æ¿¡¼­ ÇùÃø ±³µÎ´Â ÇùÃø ±³µÎ³¢¸®, ¼³Ãø ±³µÎ´Â ¼³Ãø ±³µÎ³¢¸® Á¢ÃËÇϰí Ãø¸é¿¡¼­ º¸¸é »óÇÏ¾Ç Ä¡¾Æ ±³µÎ´Â ´ëÇÕÄ¡ ÇÏ¾Ç Ä¡¾Æ ±³µÎÀÇ ÈĹ濡 À§Ä¡ÇÑ´Ù. Áï »ó¾Ç Ä¡¾Æ ±³µÎÀÇ ±Ù½É°æ»ç¸éÀº ´ëÇÕÄ¡ ±³µÎÀÇ ¿ø½É °æ»ç¸é¿¡ Á¢ÃËÇÑ´Ù.
  • working cast
    ÀÛ¾÷ ¸ðÇü
    ¿ø¸ðÇüÀÇ Á¤È®ÇÑ ÀçÇö. ¿ø¸ðÇü¿¡ ¼Õ»óÀÌ °¡´Â °ÍÀ» ¹æÁöÇϱâ À§ÇØ ÁÖÁ¶¹°ÀÇ ÀÏÂ÷Àû ÀûÇÕ ½Ã »ç¿ëÇÑ´Ù.
  • working condyle
    ÀÛ¾÷Ãø °úµÎ
    ÀúÀÛÇÒ ¶§ ÇϾÇÀÇ ±â´ÉÀ» ´ã´çÇÏ´Â ÂÊÀÇ °úµÎ¸¦ ¸»ÇÑ´Ù. Áï, Ä¡¾Æ¸¦ Á¢ÃËÇÏ¿© ¾Ã°Ô µÇ´Â ÂÊÀÇ °úµÎ¸¦ ÀÛ¾÷Ãø °úµÎ¶ó°í Çϸç ÀϹÝÀûÀ¸·Î ¾à°£ ¿Ü¹æÀ̳ª ÈĿܹæÀ¸·Î À̵¿ÇÏ¿© ȸÀüÇÏ´Â °æ¿ì°¡ ¸¹´Ù.
  • working definition
    ÀÓ»óÀû Á¤ÀÇ
  • working distance
    ÀÛµ¿°Å¸®, ÀÛ¾÷¸®
    Çö¹Ì°æ¿¡¼­ ¹°Ã¼¿Í ´ë¹° ·»ÁîÀÇ °Å¸®.
  • working length
    ±Ù°üÀå
  • working model for bridgework
    °¡°ø ÀÇÄ¡ ÀÛ¾÷ ¸ðÇü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
hypnotic relationship Relationship between hypnotiser, or hypnotist, and the hypnotised, or hypnotee.
(05 Mar 2000)
structure-activity relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Other factors contributing to structure-activity relationship include chemical reactivity, electronic effects, resonance, and inductive effects.
(12 Dec 1998)
dose-response relationship Relationship in which a change in the amount, intensity, or duration of exposure is associated with a change in risk of a specified outcome.
(05 Mar 2000)
dose-response relationship, drug The relationship between the dose of an administered drug and the response of the organism to the drug.
(12 Dec 1998)
dose-response relationship, immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell.
(12 Dec 1998)
dose-response relationship, radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation.
(12 Dec 1998)
object relationship In the behavioural sciences, the emotional bond between an individual and another person (or between two groups), as opposed to the individual's (or group's) interest in him or herself (itself).
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á